Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / SHS NEW
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
1,939,475
-
Shares change
-
+44,913
-
Total reported value, excl. options
-
$32,761,000
-
Value change
-
-$407,689
-
Number of buys
-
7
-
Number of sells
-
-7
-
Price
-
$16.9
Significant Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q3 2021
17 filings reported holding CLGN - CollPlant Biotechnologies Ltd - SHS NEW as of Q3 2021.
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,939,475 shares
.
Largest 10 shareholders include INVESTMENT MANAGEMENT OF VIRGINIA LLC (570,901 shares), Roumell Asset Management, LLC (563,030 shares), VILLERE ST DENIS J & CO LLC (248,150 shares), ARK Investment Management LLC (191,290 shares), STATE STREET CORP (182,266 shares), BROWN ADVISORY INC (61,450 shares), BENJAMIN F. EDWARDS & COMPANY, INC. (57,644 shares), Weil Company, Inc. (24,558 shares), Sigma Planning Corp (18,635 shares), and RENAISSANCE TECHNOLOGIES LLC (10,001 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.